TransMedics Executives Load Up on Zero‑Cost RSUs as Insider Confidence Fuels Bullish Rally
Insider buying at TransMedics signals confidence in its transplant tech pipeline, offering investors a potential catalyst for valuation reassessment.
3 minutes to read


